We are live on ! Find out more
LSA

L & S Advisors Portfolio holdings

AUM $795M
1-Year Est. Return 52.77%
This Fund
S&P 500
This Quarter Est. Return
+18.27%
1 Year Est. Return
+52.77%
3 Year Est. Return
+187.16%
5 Year Est. Return
+324.2%
10 Year Est. Return
+1,741.32%
AUM
$863M
AUM Growth
+$136M
Cap. Flow
+$4.89M
Cap. Flow %
0.57%
Top 10 Hldgs %
18.05%
Holding
374
New
75
Increased
96
Reduced
86
Closed
42

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$5.92M
2
PFE icon
Pfizer
PFE
+$4.9M
3
LEN icon
Lennar Class A
LEN
+$4.58M
4
GS icon
Goldman Sachs
GS
+$4.53M
5
NEE icon
NextEra Energy
NEE
+$4.11M

Sector Composition

Rank Sector Weight
1 Technology 22.83%
2 Consumer Discretionary 11.93%
3 Industrials 11.47%
4 Healthcare 9.1%
5 Communication Services 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBHT icon
251
JB Hunt Transport Services
JBHT
$26.4B
-29,997
Closed -$3.79M
JCI icon
252
Johnson Controls International
JCI
$84.8B
-68,194
Closed -$2.79M
LEN icon
253
Lennar Class A
LEN
$21.2B
-57,935
Closed -$4.58M
LHX icon
254
L3Harris
LHX
$57.4B
-11,618
Closed -$1.97M
LII icon
255
Lennox International
LII
$18.9B
-7,001
Closed -$1.91M
LIN icon
256
Linde
LIN
$241B
-8,337
Closed -$1.99M
MMM icon
257
3M
MMM
$94.2B
-20,064
Closed -$2.69M
MS icon
258
Morgan Stanley
MS
$328B
-53,896
Closed -$2.61M
ORCL icon
259
Oracle
ORCL
$332B
-46,774
Closed -$2.79M
PENN icon
260
PENN Entertainment
PENN
$2.83B
-53,708
Closed -$3.9M
PFE icon
261
Pfizer
PFE
$145B
-140,628
Closed -$4.9M
QUAD icon
262
Quad
QUAD
$436M
-15,350
Closed -$47K
REGN icon
263
Regeneron Pharmaceuticals
REGN
$72.2B
-6,894
Closed -$3.86M
SBAC icon
264
SBA Communications
SBAC
$19.1B
-5,839
Closed -$1.86M
SMG icon
265
ScottsMiracle-Gro
SMG
$4.1B
-17,475
Closed -$2.67M
TGI
266
DELISTED
Triumph Group
TGI
-25,000
Closed -$163K
TNDM icon
267
Tandem Diabetes Care
TNDM
$1.22B
-10,127
Closed -$1.15M
TREX icon
268
Trex
TREX
$4.68B
-17,915
Closed -$1.28M
U icon
269
Unity
U
$13B
-2,500
Closed -$218K
URI icon
270
United Rentals
URI
$70.9B
-13,027
Closed -$2.27M
VKTX icon
271
Viking Therapeutics
VKTX
$3.9B
-114,988
Closed -$669K
VRM icon
272
Vroom Inc
VRM
$37.5M
-288
Closed -$1.19M
VRTX icon
273
Vertex Pharmaceuticals
VRTX
$123B
-4,535
Closed -$1.23M
ONC
274
BeOne Medicines Ltd
ONC
$33.9B
-1,000
Closed -$286K
AYX
275
DELISTED
Alteryx Inc
AYX
-13,706
Closed -$1.56M

Similar funds

L & S Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, L & S Advisors held 374 positions worth $863M, up 19% from $727M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

L & S Advisors's Q4 2020 filing shows 75 new, 96 increased, 86 reduced and 42 closed positions. Its largest new stake was Caterpillar: 35,686 shares worth $6.5M. The largest sale was Merck, an estimated $5.92M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • L & S Advisors's largest Q4 2020 buy was Caterpillar: 35,686 shares worth $6.5M.
  • L & S Advisors added most to iShares Russell 2000 ETF in Q4 2020, an estimated $5.37M increase.
  • L & S Advisors's biggest Q4 2020 reduction was Merck, cutting an estimated $5.92M.
  • L & S Advisors fully exited Pfizer in Q4 2020, selling an estimated $4.9M.
  • L & S Advisors's ten largest holdings make up 18% of its $863M portfolio in Q4 2020.
  • L & S Advisors opened 75 new positions and closed 42 in Q4 2020.
  • L & S Advisors's portfolio value rose 19% quarter-over-quarter to $863M.

Based on L & S Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.